You are here

Article info

Article menu
Download PDFPDF
Cardiovascular medicine
Cost effectiveness of ramipril treatment for cardiovascular risk reduction

Authors

  • I S Malik aBritish Heart Foundation Cardiovascular Medicine Unit, National Heart and Lung Institute, Imperial College School of Medicine, Hammersmith Hospital, DuCane Road, London, W12 0NN, UK, bDepartment of Cardiology, National Heart and Lung Institute, Imperial College School of Medicine PubMed articlesGoogle scholar articles
  • V K Bhatia aBritish Heart Foundation Cardiovascular Medicine Unit, National Heart and Lung Institute, Imperial College School of Medicine, Hammersmith Hospital, DuCane Road, London, W12 0NN, UK, bDepartment of Cardiology, National Heart and Lung Institute, Imperial College School of Medicine PubMed articlesGoogle scholar articles
  • J S Kooner aBritish Heart Foundation Cardiovascular Medicine Unit, National Heart and Lung Institute, Imperial College School of Medicine, Hammersmith Hospital, DuCane Road, London, W12 0NN, UK, bDepartment of Cardiology, National Heart and Lung Institute, Imperial College School of Medicine PubMed articlesGoogle scholar articles
  1. Dr Maliki.malik{at}ic.ac.uk
View Full Text

Citation

Malik IS, Bhatia VK, Kooner JS
Cost effectiveness of ramipril treatment for cardiovascular risk reduction
Heart 2001;85:539-543.

Publication history

  • Accepted December 5, 2000
  • First published May 1, 2001.
Online issue publication 
January 09, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

British Cardiac Society